Dr. Jason Yi Zhou
Jason Zhou was appointed to lead the newly created CR-CP Life Science Fund in 2019, which was sponsored by China Resources Group and Charoen Pokphand Group. Previously, he served in China Resource Group as the strategy director of the healthcare business sector since 2012. In addition to his management and operational responsibilities, Dr Zhou intensively…
Raphaël Wisniewski
Alex C. Sapir
Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Dr. Ken Powell
Nanna Lüneborg
Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).